If you were to listen to much of the reporting about the Hobby Lobby victory before the U.S. Supreme Court, you’d probably come away thinking the Green Family (who owns Hobby Lobby) has something against contraception.
Yet in reality, Hobby Lobby asked the High Court to protect their religious freedom to not be forced to pay only for abortion-inducing drugs under the Affordable Care Act – drugs like Plan B and Ella.
[What is Plan B? Find out at AZPolicyPages.com.]
Recently on Politics Unplugged, CAP President Cathi Herrod dispelled the lies and misconceptions about this ruling and made it clear that like CAP-supported SB 1062, this ruling was about one thing: ensuring every American is free to live and work according to their faith.
Click the video below to watch the debate:
Cathi Herrod was on Faith Talk 1360′s Koinonia with Tom Brown to discuss the Hobby Lobby Stores and Conestoga Wood Specialties win, where the United States Supreme Court said that under the federal Religious Freedom Restoration Act, closely held private businesses cannot be forced to pay for abortion-causing drugs in their insurance plans. In Conestoga Wood Specialties v. Burwell and Burwell v. Hobby Lobby Stores, the U.S. Supreme Court affirmed religious freedom and the importance that every American should be free to live and work according to their faith. Cathi emphasizes the important distinction that Hobby Lobby did not want to provide abortion-causing drugs to their employees, but were willing to offer 16 out of 20 so-called contraceptives.
A few weeks ago, Cathi shared with you the story of the Isaiah 58 Project in Quartzsite, Arizona.
La Paz County required the church to pay the tax even though both state law and the Arizona Department of Revenue say the church isn’t liable.
Alliance Defending Freedom attorneys represent Church of the Isaiah 58 Project of Arizona in a lawsuit over the taxes.
Read more at http://www.adfmedia.org/News/PRDetail/4680
Q: What do all of these drugs have in common?
Actiq: For the management of breakthrough cancer pain in patients with malignancies who are already receiving and who are tolerant to opioid therapy for their underlying persistent cancer pain.
Revlimid: Provides for the treatment of patients with transfusion-dependent anemia due to Low- or Intermediate-1-risk myelodysplastic syndromes associated with a deletion 5q cytogenetic abnormality with or without additional cytogenetic abnormalities.
Plenaxis: Provides for the use of Plenaxis (abarelix for injectable suspension, 100 mg) for the palliative treatment of men with advanced symptomatic prostate cancer.
Mifeprex: For medical termination of intrauterine pregnancy through 49 days’ pregnancy. (more…)